Billionaire Andreas Halvorsen’s Top 15 Long-Term Stock Picks

Page 8 of 15

8. Royalty Pharma plc (NASDAQ:RPRX)

Number of Hedge Fund Holders: 33

Viking Global’s Stake: $342.1 million  

Royalty Pharma plc (NASDAQ:RPRX) is a New York-based firm that operates in the pharma sector. The following factors make this company stand out as a worthwhile investment. Firstly, as per the report of the third quarter of 2024, the company delivered strong growth of approximately 15% in Portfolio Receipts and raised full-year guidance. Additionally, the company also strengthened its portfolio by adding royalties on three innovative therapies over the last three months, increasing Capital Deployment to approximately $1.2 billion in the third quarter and $2.6 billion year-to-date. Secondly, the company plans to become an integrated company by acquiring its external manager, RP Management, LLC. This simplified structure would benefit shareholders through strengthened shareholder alignment, enhanced governance and increased economic return on investments. Moreover, the board also authorized a $3 billion share repurchase program; $2 billion of shares are intended to be repurchased in 2025, subject to market conditions.

Page 8 of 15